OptiBiotix Health (OPTI) Share Price, News & Analysis

Company Overview

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators primarily in the United Kingdom. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that impacts human physiology deriving potential health benefits. Its products include Slimbiome, a natural ingredient, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; CholBiome, a food supplement for maintaining healthy levels of cholesterol; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; LPGOS, a galactooligosaccharid that is used in food products and applications, which helps in reducing cardiovascular risk factors and enhancing health; and Sweetbiotix, a sweetener for use in food and beverages. The company's products prevents and manages chronic lifestyle diseases, including obesity, hypercholesterolemia, and diabetes. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.

Key Stats

• Today's Range: 12.12 to 13.04
• 50-Day Range: 10.13 to 18.77
• 52-Week Range: 10 to 35
• Volume: 103,972 shs
• Average Volume: 312,681 shs
• Market Capitalization: £12.00 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

OPTI Stock Analysis - Frequently Asked Questions

How have OPTI shares performed this year?

OptiBiotix Health's stock was trading at GBX 26.75 on January 1st, 2024. Since then, OPTI stock has decreased by 54.2% and is now trading at GBX 12.25.
View the best growth stocks for 2024 here.

How were OptiBiotix Health's earnings last quarter?

OptiBiotix Health Plc (LON:OPTI) announced its quarterly earnings data on Thursday, September, 24th. The company reported ($0.70) EPS for the quarter.

How do I buy shares of OptiBiotix Health?

Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of OptiBiotix Health own?

Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO).

Company Calendar

• Last Earnings: 9/24/2020
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Pharmaceutical Products
• Current Symbol: LON:OPTI
• Previous Symbol: LON:CMI
• CUSIP: N/A
• CIK: N/A
• Web: www.optibiotix.com
• Phone: +44-20-79338780
• Fax: N/A
• Employees: 1
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-2,980,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -36.34%
• Return on Assets: -13.93%

Debt

• Debt-to-Equity Ratio: 4.51
• Current Ratio: 6.18
• Quick Ratio: 7.89

Sales & Book Value

• Annual Sales: £1.26 million
• Price / Sales: 9.42
• Cash Flow: GBX 1.40 per share
• Price / Cash Flow: 8.68
• Book Value: GBX 8 per share
• Price / Book: 1.52

Miscellaneous

• Outstanding Shares: 97,940,000
• Free Float: N/A
• Market Cap: £11.87 million
• Optionable: Not Optionable
• Beta: 1.71